Publication - Impact assessment
Coronavirus (COVID-19) Highest Risk (formerly Shielding) List end: equality and fairer Scotland impact assessment
This presents an assessment of any differential impact on each of the protected characteristics of the decision to end Scotland’s Covid Highest Risk List, formerly the Shielding List and considers any possible inequality of outcomes of the policy due to socio-economic differences.
Annex 2: Medical Charity Stakeholder Engagement
The following section shows an at a glance summary of Medical Charities Stakeholders we have engaged with regarding the ending of the Highest Risk List.
- Scottish Cancer Coalition
- Lymphoma Action
- Myeloma UK
- Leukaemia UK
- Teenage Cancer Trust
- Blood Cancer Alliance
- Anthony Nolan Trust
- Macmillan Cancer Support
- Cancer Research UK
- Action Duchenne
- Kidney Kids
- Chest, Heart & Stroke Scotland
- Diabetes UK (Scotland)
- Genetic Alliance UK
- IMD Scotland
- Rare Disease UK
- Downs Syndrome Scotland
- MND Scotland
- Scottish Huntington's Association
- My Aware (Myasthenia Gravis charity)
- My Name'5 Doddie
- Asthma UK/ British Lung Foundation
- NARA (The breathing charity)
- Chest, Heart and Stroke Scotland
- Vasculitis UK
- CGD Society UK (Granulomatous Disease)
- Sickle Cell Society
- Sickle Cell Thalassaemia Support Group Scotland
- Versus Arthritis
- Edinburgh Network for Crohn's and Colitis
- Revive MS
- MS Society Scotland
- Psoriasis Scotland
- Crohn's and Colitis UK
- Neurological Alliance of Scotland
- British Thyroid Foundation, Edinburgh Group
- Lupus UK
- British Sjogren's Syndrome
- Polymyalgia Rheumatica and Giant Cell Arteritis
- Kawasaki Synndrome Support Group
- Scleroderma & Raynauds UK
- HIV Scotland
- British Liver Trust
- Kidney Care UK
- Cystic Fibrosis UK
- British Heart Foundation
- Inclusion Scotland
Contact
Email: Shielding@gov.scot
There is a problem
Thanks for your feedback